Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung Cancer

References

• Raviv S, Hawkins KA, DeCamp MM, Kalhan R. Lung cancer in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1138–46. doi:10.1164/rccm.201008-1274CI.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–57. doi:10.1183/09031936.00133805.
   PubMed Web of Science ®Google Scholar
• Licker MJ, Widikker I, Robert J, Frey J-G, Spiliopoulos A, Ellenberger C. Schweizer A, Tschopp JM. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006;81(5):1830–7. doi:10.1016/j.athoracsur.2005.11.048.
   PubMed Web of Science ®Google Scholar
• Thomas PA, Berbis J, Baste J-M, Le Pimpec-Barthes F, Tronc F, Falcoz P-E., Dahan M7, Loundou A. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes. J Thorac Cardiovasc Surg. 2015;149(1):73–82. doi:10.1016/j.jtcvs.2014.09.063.
   PubMed Web of Science ®Google Scholar
• Strand T-E, Rostad H, Damhuis RAM, Norstein J. Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude. Thorax. 2007;62(11):991–7. doi:10.1136/thx.2007.079145.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37(1):95–101. doi:10.1016/S0169-5002(02)00014-4
   PubMed Web of Science ®Google Scholar
• Schussler O, Alifano M, Dermine H, Strano S, Casetta A, Sepulveda S. Chafik A, Coignard S, Rabbat A, Regnard JF. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med. 2006;173(10):1161–9. doi:10.1164/rccm.200510-1556OC.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–52. doi:10.1136/thorax.57.10.847
   PubMed Web of Science ®Google Scholar
• Friedlander AL, Lynch D, Dyar LA, Bowler RP. Phenotypes of chronic obstructive pulmonary disease. COPD. 2007;4(4):355–84. doi:10.1080/15412550701629663.
   PubMedGoogle Scholar
• Yusen RD. Evolution of the GOLD documents for the diagnosis. management. and prevention of chronic obstructive pulmonary disease. Controversies and questions. Am J Respir Crit Care Med. 2013;188(1):4–5. doi:10.1164/rccm.201305-0846ED.
   PubMed Web of Science ®Google Scholar
• Kim H-J, Lee J. Park YS, Lee C-H, Lee S-M, Yim J-J. Impact of GOLD groups of chronic pulmonary obstructive disease on surgical complications. Int J Chron Obstruct Pulmon Dis. 2016;11:281–7. doi:10.2147/COPD.S95046.
   PubMedGoogle Scholar
• Perez T, Burgel PR, Paillasseur J-L, Caillaud D, Deslée G, Chanez P, Roche N. Modified Medical Research Council Scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1663–72. doi:10.2147/COPD.S82408.
   PubMed Web of Science ®Google Scholar
• Karloh M, Fleig Mayer A, Maurici R, Pizzichini MMM, Jones PW. Pizzichini E. The COPD assessment test: what do we know so far?: A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest. 2016;149(2):413–25. doi:10.1378/chest.15-175214.
   PubMed Web of Science ®Google Scholar
• Herrmann C. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17–41. doi:10.1016/S0022-3999(96)00216-4
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–22. doi:10.1164/ajrccm.157.5.9709032.
   PubMed Web of Science ®Google Scholar
• Birim O, Maat APWM, Kappetein AP, van Meerbeeck JP, Damhuis R A. M, Bogers AJJC. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardio-Thorac Surg. 2003;23(1):30–4. doi:10.1016/j.ejcts.2005.06.046
   PubMed Web of Science ®Google Scholar
• Falcoz PE, Conti M. Brouchet L, Chocron S, Puyraveau M, Mercier M. Etievent JP, Dahan M. The thoracic surgery scoring system (Thoracoscore): risk model for in-hospital death in 15.183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg. 2007;133(2):325–32. doi:10.1016/j.jtcvs.2006.09.020.
   PubMed Web of Science ®Google Scholar
• Ong K-C, Earnest A. Lu S-J. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005;128(6):3810–6. doi:10.1378/chest.128.6.3810.
   PubMed Web of Science ®Google Scholar
• Eberhardt WE1, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A 3rd, Goldstraw P, Rami-Porta R. The IASLC lung cancer staging project: Proposals for the revision of the M descriptors in the forthcoming Eighth Edition of the TNM classification of lung cancer. J Thorac Oncol. 2015;10(11):1515–22. doi:10.1097/JTO.0000000000000673.
   PubMed Web of Science ®Google Scholar
• Jose Belda, Cavalcanti M, Ferrer M, Serra M, Puig de la Bellacasa J, Canalis E, Torres A. Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest. 2005;128(3):1571–9. doi:10.1378/chest.128.3.1571
   PubMed Web of Science ®Google Scholar
• Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res. 2013;14:116. doi:10.1186/1465-9921-14-116.
   PubMed Web of Science ®Google Scholar
• Hurst JR. Vestbo J. Anzueto A. Locantore N. Müllerova H. Tal-Singer R. Miller B, Lomas DA, Agusti A, Macnee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–38. doi:10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Alifano M, Mansuet-Lupo A, Lococo F, Roche N, Bobbio A, Canny E. Schussler O, Dermine H, Régnard JF, Burroni B. et al. Systemic inflammation. nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PloS One. 2014;9(9):e106914. doi:10.1371/journal.pone.0106914.
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL. Gouskova NA, Hansel NN, Hoffman EA, Kanner RE et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–21. doi:10.1056/NEJMoa1505971.
   PubMed Web of Science ®Google Scholar
• Novoa N, Jiménez MF, Aranda JL, Rodriguez M, Ramos J, Gómez Hernández MT. Varela G. Effect of implementing the European guidelines for functional evaluation before lung resection on cardiorespiratory morbidity and 30-day mortality in lung cancer patients: a case-control study on a matched series of patients. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2014;45(4):e89–93; discussion e93. doi:10.1093/ejcts/ezt596.
   PubMed Web of Science ®Google Scholar
• Agostini P, Cieslik H, Rathinam S, Bishay E, Kalkat MS, Rajesh PB. Steyn RS, Singh S, Naidu B. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax. 2010;65(9):815–8. doi:10.1136/thx.2009.123083.
   PubMed Web of Science ®Google Scholar
• Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier J-P. Varela G. Licker M, Ferguson MK, Faivre-Finn C, Huber RM, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34(1):17–41. doi:10.1183/09031936.00184308.
   PubMed Web of Science ®Google Scholar
• Thomas PA, Berbis J, Falcoz P-E, Le Pimpec-Barthes F, Bernard A, Jougon J. Porte H, Alifano M, Dahan M. National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2014;45(4):652–9; discussion 659. doi:10.1093/ejcts/ezt452.
   PubMed Web of Science ®Google Scholar
• Hervochon R, Bobbio A, Guinet C, Mansuet-Lupo A, Rabbat A, Régnard J-F. Roche N, Damotte D, Iannelli A, Alifano M. Body mass index and total psoas area affect outcomes in patients undergoing pneumonectomy for cancer. Ann Thorac Surg. 2017;103(1):287–95. doi:10.1016/j.athoracsur.2016.06.077.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11:181. doi:10.1186/1741-7015-11-181.
   PubMed Web of Science ®Google Scholar